BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10525449)

  • 1. Peptide carriers: A helicoid-type sequential oligopeptide carrier (SOC(n)) for multiple anchoring of antigenic/immunogenic peptides.
    Sakarellos-Daitsiotis M; Tsikaris V; Vlachoyiannopoulos PG; Tzioufas AG; Moutsopoulos HM; Sakarellos C
    Methods; 1999 Sep; 19(1):133-41. PubMed ID: 10525449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential oligopeptide carriers, SOCn, as scaffolds for the reconstitution of antigenic proteins: applications in solid phase immunoassays.
    Sakarellos-Daitsiotis M; Alexopoulos C; Sakarellos C
    J Pharm Biomed Anal; 2004 Mar; 34(4):761-9. PubMed ID: 15019054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new helicoid-type sequential oligopeptide carrier (SOC(n)) for developing potent antigens and immunogens.
    Sakarellos-Daitsiotis M; Tsikaris V; Sakarellos C; Vlachoyiannopoulos PG; Tzioufas AG; Moutsopoulos HM
    Vaccine; 1999 Sep; 18(3-4):302-10. PubMed ID: 10506655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The position of the LysN epsilon H2-grafted antigens along the sequential oligopeptide carrier, Ac-(Aib-Lys-Aib-Gly)n (SOCn-II), influences the antibody recognition: application to the Sm main autoimmune epitope.
    Alexopoulos C; Tsikaris V; Rizou C; Sakarellos-Daitsiotis M; Sakarellos C; Cung MT; Marraud M; Vlachoyiannopoulos PG; Moutsopoulos HM
    Biopolymers; 2000 Jul; 54(1):1-10. PubMed ID: 10799976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sequential oligopeptide carriers (SOCn) in the design of potent Leishmania gp63 immunogenic peptides.
    Tsikaris V; Sakarellos C; Sakarellos-Daitsiotis M; Cung MT; Marraud M; Konidou G; Tzinia A; Soteriadou KP
    Pept Res; 1996; 9(5):240-7. PubMed ID: 9000250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A palmitoyl-tailed sequential oligopeptide carrier for engineering immunogenic conjugates.
    Kargakis M; Zevgiti S; Krikorian D; Sakarellos-Daitsiotis M; Sakarellos C; Panou-Pomonis E
    Vaccine; 2007 Sep; 25(37-38):6708-12. PubMed ID: 17692437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of epitope spreading after immunization with the major Sm epitope P-P-G-M-R-P-P anchored to sequential oligopeptide carriers (SOCs).
    Vlachoyiannopoulos PG; Petrovas C; Tzioufas AG; Alexopoulos C; Tsikaris V; Guialis A; Nakopoulou L; Sakarellos-Daitsiotis M; Sakarellos C; Davaris P; Moutsopoulos HM
    J Autoimmun; 2000 Feb; 14(1):53-61. PubMed ID: 10648116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of sequential oligopeptide carriers on the bioactive structure of conjugated epitopes: comparative study of the conformation of a Herpes simplex virus glycoprotein gD-1 epitope in the free and conjugated form, and protein "built-in" crystal structure.
    Krikorian D; Stavrakoudis A; Biris N; Sakarellos C; Andreu D; de Oliveira E; Mezö G; Majer Z; Hudecz F; Welling-Wester S; Cung MT; Tsikaris V
    Biopolymers; 2006; 84(4):383-99. PubMed ID: 16493659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and application of a new class of sequential oligopeptide carriers (SOCn) for multiple anchoring of antigenic peptides--application to the acetylcholine receptor (AChR) main immunogenic region.
    Tsikaris V; Sakarellos C; Sakarellos-Daitsiotis M; Orlewski P; Marraud M; Cung MT; Vatzaki E; Tzartos S
    Int J Biol Macromol; 1996 Oct; 19(3):195-205. PubMed ID: 8910060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innovative, multifunctional sequential oligopeptide carriers Soc(n)-I and SOC(n)-II: functions-technology-perspectives.
    Alexopoulos C; Krikorian D; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C
    Protein Pept Lett; 2005 Aug; 12(6):601-7. PubMed ID: 16101403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and comparison of antibody recognition of conjugates containing herpes simplex virus type 1 glycoprotein D epitope VII.
    Mezö G; de Oliveira E; Krikorian D; Feijlbrief M; Jakab A; Tsikaris V; Sakarellos C; Welling-Wester S; Andreu D; Hudecz F
    Bioconjug Chem; 2003; 14(6):1260-9. PubMed ID: 14624643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential oligopeptide carriers: from thermal polymerization to the construction of reconstituted antigenic and immunogenic conjugates.
    Sakarellos C; Krikorian D; Sakarellos-Daitsiotis M
    J Pept Sci; 2005 May; 11(5):254-7. PubMed ID: 15838937
    [No Abstract]   [Full Text] [Related]  

  • 13. Solvent-induced beta-hairpin to helix conformational transition in a designed peptide.
    Awasthi SK; Shankaramma SC; Raghothama S; Balaram P
    Biopolymers; 2001 Apr; 58(5):465-76. PubMed ID: 11241218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier design: conformational studies of amino acid (X) and oligopeptide (X-DL-Alam) substituted poly (L-lysine).
    Mezö G; Kajtár J; Hudecz F; Szekerke M
    Biopolymers; 1993 Jun; 33(6):873-85. PubMed ID: 8318662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concept and design of a new class of sequential oligopeptide carriers (SOC) for covalent attachment of multiple antigenic peptides.
    Tsikaris V; Sakarellos C; Cung MT; Marraud M; Sakarellos-Daitsiotis M
    Biopolymers; 1996 Mar; 38(3):291-3. PubMed ID: 8906964
    [No Abstract]   [Full Text] [Related]  

  • 16. Fasciola gigantica cathepsin L proteinase-based synthetic peptide for immunodiagnosis and prevention of sheep fasciolosis.
    Jezek J; El Ridi R; Salah M; Wagih A; Aziz HW; Tallima H; El Shafie MH; Khalek TA; Ammou FF; Strongylis C; Moussis V; Tsikaris V
    Biopolymers; 2008; 90(3):349-57. PubMed ID: 17549696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A complementary La/SSB epitope anchored to Sequential Oligopeptide Carrier regulates the anti-La/SSB response in immunized animals.
    Voitharou C; Krikorian D; Sakarellos C; Sakarellos-Daitsiotis M; Panou-Pomonis E
    J Pept Sci; 2008 Sep; 14(9):1069-76. PubMed ID: 18618423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial carriers: a strategy for constructing antigenic/immunogenic conjugates.
    Sakarellos-Daitsiotis M; Krikorian D; Panou-Pomonis E; Sakarellos C
    Curr Top Med Chem; 2006; 6(16):1715-35. PubMed ID: 17017953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates.
    Krikorian D; Panou-Pomonis E; Voitharou C; Sakarellos C; Sakarellos-Daitsiotis M
    Bioconjug Chem; 2005; 16(4):812-9. PubMed ID: 16029022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the role of the C-H...O hydrogen bond stabilized polypeptide chain reversal at the C-terminus of designed peptide helices. Structural characterization of three decapeptides.
    Aravinda S; Shamala N; Bandyopadhyay A; Balaram P
    J Am Chem Soc; 2003 Dec; 125(49):15065-75. PubMed ID: 14653741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.